Altogether, this suggests that neuroprotective effects of NMNAT1 on behavioral symptoms, and possibly tau pathology, would only occur after disease onset, as was also seen in a Drosophila model of tauopathy [18]. The gene discussed is MAPT; the disease is tauopathy.